Showing results (1041-1050 of 1,293) with videos related to
Sort By:
Pageof 130
Antimicrobial Agents and Chemotherapy|December 25, 2002
Mannopeptimycins, new cyclic glycopeptide antibiotics produced by Streptomyces hygroscopicus LL-AC98: antibacterial and mechanistic activitiesM P Singh, P J Petersen, W J Weiss, et al.The New England Journal of Medicine|July 12, 2002
A controlled trial of arthroscopic surgery for osteoarthritis of the kneeJ Bruce Moseley, Kimberly O'Malley, Nancy J Petersen, et al.Bioorganic & Medicinal Chemistry Letters|October 12, 2005
Pulvinones as bacterial cell wall biosynthesis inhibitorsSchuyler Antane, Craig E Caufield, William Hu, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 24, 2007
Streptococcus pneumoniae: proteomics of surface proteins for vaccine developmentC Morsczeck, T Prokhorova, J Sigh, et al.Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|February 19, 2019
Dopamine effects on frontal cortical blood flow and motor inhibition in Parkinson's diseasePaula Trujillo, Nelleke C van Wouwe, Ya-Chen Lin, et al.BMC Cardiovascular Disorders|March 8, 2023
Peripheral artery disease in patients with schizophrenia as compared to controlsLinea Rosenberg Jørgensen, Cathrine Linnea Hegtmann, Sune P V Straszek, et al.The Lancet. HIV|February 10, 2023
Effects of clinical, comorbid, and social determinants of health on brain ageing in people with and without HIV: a retrospective case-control studyKalen J Petersen, Tina Lu, Julie Wisch, et al.The Journal of Physical Chemistry Letters|August 14, 2020
Brightly Luminescent CsPbBr3 Nanocrystals through UltracentrifugationAaron Forde, Jeffrey A Fagan, Richard D Schaller, et al.Depression and Anxiety|July 14, 2011
The impact of Purple Heart commendation and PTSD on mortality rates in older veteransTim Kimbrell, Jeffrey M Pyne, Mark E Kunik, et al.Arthritis and Rheumatism|September 2, 2006
Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in European patients with rheumatoid arthritis who had an incomplete response to methotrexateR N Maini, P C Taylor, J Szechinski, et al.Pageof 130